Vanda Pharmaceuticals
VNDA
#8812
Rank
โ‚ฌ0.18 B
Marketcap
3,14ย โ‚ฌ
Share price
-6.13%
Change (1 day)
-29.56%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2026 (TTM): -3,98ย โ‚ฌ

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -4,21ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -3,40ย โ‚ฌ a decrease over its 2024 EPS that were of -0,29ย โ‚ฌ.

EPS history for Vanda Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-3,98ย โ‚ฌ17.13%
2025-3,40ย โ‚ฌ1065.63%
2024-0,29ย โ‚ฌ-710.9%
20230,04773ย โ‚ฌ-56.35%
20220,11ย โ‚ฌ-80%
20210,55ย โ‚ฌ
20191,98ย โ‚ฌ334%
20180,46ย โ‚ฌ-247.06%
2017-0,31ย โ‚ฌ-19.05%
2016-0,38ย โ‚ฌ-55.32%
2015-0,86ย โ‚ฌ-347.37%
20140,35ย โ‚ฌ-156.72%
2013-0,61ย โ‚ฌ-31.63%
2012-0,89ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,09ย โ‚ฌ-244.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4,78ย โ‚ฌ-213.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
0,65ย โ‚ฌ-115.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
28,15ย โ‚ฌ-768.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,90ย โ‚ฌ-121.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,12ย โ‚ฌ-197.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-4,00ย โ‚ฌ-4.98%๐Ÿ‡บ๐Ÿ‡ธ USA